Company / Income Tax
Avalo Therapeutics, Inc. Income Tax History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$165.0K
FY2025
5-year range
-$196.0K / $165.0K
FY2021-FY2025
Trend
+44.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax has fluctuated over the past 9 years, ranging from -$3M in FY2020 to $2M in FY2017.
Based on SEC 10-K filings.
$165,000 in FY2025 with a 3-year CAGR of +80.6%.
Increased from $14,000 to $165,000 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- +80.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +80.6%, indicating consistent growth.
- In FY2025, income tax increased 44.7% year-over-year.
- Peak income tax was recorded in FY2017.
- Lowest income tax in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $165.0K | +44.7% |
| FY2024 | $114.0K | +714.3% |
| FY2023 | $14.0K | -50.0% |
| FY2022 | $28.0K | +114.3% |
| FY2021 | -$196.0K | +93.0% |
| FY2020 | -$2.8M | -1096.4% |
| FY2019 | $280.3K | +666.7% |
| FY2018 | -$49.5K | -102.5% |
| FY2017 | $2.0M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026